1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Drug Discovery and Development Analysis & Statistics, January 2013 (p50)

Drug Discovery and Development Analysis & Statistics, January 2013 (p50)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

1471-1500 of about 1 800 reports

Purchase Reports From Reputable Market Research Publishers

Triple Analysis: Lung Cancer, Prostate Cancer and Peptides

Triple Analysis: Lung Cancer, Prostate Cancer and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Prostate Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated according ...

  • Industries : Pathology, Drug and Medication, General Medicine and Specialty Medicine, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Lung Cancer, Apoptosis and Peptides

Triple Analysis: Lung Cancer, Apoptosis and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lung Cancer), one mechanism/target/effect area (Apoptosis) and one compound specific area (Peptides). ...

  • Industries : Drug and Medication, Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Drug Discovery and Development
Triple Analysis: Lung Cancer, Angiogenesis and Peptides

Triple Analysis: Lung Cancer, Angiogenesis and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lung Cancer), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Peptides). ...

  • Industries : Drug and Medication, Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Drug Discovery and Development
Triple Analysis: Lung Cancer, Protein Kinase Inhibitors and Peptides

Triple Analysis: Lung Cancer, Protein Kinase Inhibitors and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lung Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific ...

  • Industries : Drug and Medication, Pharmaceutical, Pathology, General Medicine and Specialty Medicine, Drug Discovery and Development
Triple Analysis: Lung Cancer, Antibodies and Peptides

Triple Analysis: Lung Cancer, Antibodies and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Lung Cancer and by the two compound strategies of Antibodies and Peptides. Each of these three individual parts is evaluated according ...

  • Industries : Drug and Medication, Pathology, Pharmaceutical, Drug Discovery and Development, General Medicine and Specialty Medicine
Triple Analysis: Lymphoma, Pancreatic Cancer and Peptides

Triple Analysis: Lymphoma, Pancreatic Cancer and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Lymphoma and Pancreatic Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated according ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Drug and Medication, Pharmaceutical
Triple Analysis: Lymphoma, Prostate Cancer and Peptides

Triple Analysis: Lymphoma, Prostate Cancer and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Lymphoma and Prostate Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated according ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Lymphoma, Apoptosis and Peptides

Triple Analysis: Lymphoma, Apoptosis and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lymphoma), one mechanism/target/effect area (Apoptosis) and one compound specific area (Peptides). ...

  • Industries : Drug and Medication, Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Drug Discovery and Development
Triple Analysis: Lymphoma, Angiogenesis and Peptides

Triple Analysis: Lymphoma, Angiogenesis and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lymphoma), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Peptides). ...

  • Industries : Drug and Medication, Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Drug Discovery and Development
Triple Analysis: Lymphoma, Protein Kinase Inhibitors and Peptides

Triple Analysis: Lymphoma, Protein Kinase Inhibitors and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lymphoma), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area ...

  • Industries : Drug and Medication, Pathology, Pharmaceutical, General Medicine and Specialty Medicine
Triple Analysis: Lymphoma, Antibodies and Peptides

Triple Analysis: Lymphoma, Antibodies and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Lymphoma and by the two compound strategies of Antibodies and Peptides. Each of these three individual parts is evaluated according ...

  • Industries : Drug and Medication, Pathology, Pharmaceutical, Drug Discovery and Development, General Medicine and Specialty Medicine
Triple Analysis: Protein Kinase Inhibitors, Antibodies and Peptides

Triple Analysis: Protein Kinase Inhibitors, Antibodies and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies by the mechanism/target/effect of Protein Kinase Inhibitors and by the two compound strategies of Antibodies and Peptides. Each of these ...

  • Industries : Drug and Medication, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Breast Cancer, Lung Cancer and Peptides

Triple Analysis: Breast Cancer, Lung Cancer and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Lung Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated according ...

  • Industries : Pathology, Drug and Medication, General Medicine and Specialty Medicine, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Breast Cancer, Lymphoma and Peptides

Triple Analysis: Breast Cancer, Lymphoma and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Lymphoma and by the compound strategy of Peptides. Each of these three individual parts is evaluated according ...

  • Industries : Pathology, Drug and Medication, General Medicine and Specialty Medicine, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Breast Cancer, Pancreatic Cancer and Peptides

Triple Analysis: Breast Cancer, Pancreatic Cancer and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Pancreatic Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated ...

  • Industries : Pathology, Drug and Medication, General Medicine and Specialty Medicine, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Breast Cancer, Prostate Cancer and Peptides

Triple Analysis: Breast Cancer, Prostate Cancer and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Breast Cancer and Prostate Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated ...

  • Industries : Drug and Medication, Pathology, Pharmaceutical, Drug Discovery and Development, General Medicine and Specialty Medicine
Triple Analysis: Breast Cancer, Apoptosis and Peptides

Triple Analysis: Breast Cancer, Apoptosis and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Breast Cancer), one mechanism/target/effect area (Apoptosis) and one compound specific area (Peptides). ...

  • Industries : Drug and Medication, Pharmaceutical, Pathology, Drug Discovery and Development
Triple Analysis: Breast Cancer, Angiogenesis and Peptides

Triple Analysis: Breast Cancer, Angiogenesis and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Breast Cancer), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Peptides). ...

  • Industries : Drug and Medication, Pharmaceutical, Pathology, Drug Discovery and Development
Triple Analysis: Breast Cancer, Protein Kinase Inhibitors and Peptides

Triple Analysis: Breast Cancer, Protein Kinase Inhibitors and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Breast Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific ...

  • Industries : Drug and Medication, Pharmaceutical, Pathology, Drug Discovery and Development
Triple Analysis: Breast Cancer, Antibodies and Peptides

Triple Analysis: Breast Cancer, Antibodies and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Breast Cancer and by the two compound strategies of Antibodies and Peptides. Each of these three individual parts is evaluated according ...

  • Industries : Drug and Medication, Pharmaceutical, Drug Discovery and Development, Pathology
Triple Analysis: Colorectal Cancer, Leukemia and Peptides

Triple Analysis: Colorectal Cancer, Leukemia and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Leukemia and by the compound strategy of Peptides. Each of these three individual parts is evaluated according ...

  • Industries : Pathology, Drug and Medication, Pharmaceutical
Triple Analysis: Colorectal Cancer, Lung Cancer and Peptides

Triple Analysis: Colorectal Cancer, Lung Cancer and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Lung Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Drug and Medication, Pharmaceutical
Triple Analysis: Colorectal Cancer, Lymphoma and Peptides

Triple Analysis: Colorectal Cancer, Lymphoma and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Lymphoma and by the compound strategy of Peptides. Each of these three individual parts is evaluated according ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Drug and Medication, Pharmaceutical
Triple Analysis: Colorectal Cancer, Pancreatic Cancer and Peptides

Triple Analysis: Colorectal Cancer, Pancreatic Cancer and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Pancreatic Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Drug and Medication, Pharmaceutical
Triple Analysis: Colorectal Cancer, Prostate Cancer and Peptides

Triple Analysis: Colorectal Cancer, Prostate Cancer and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Prostate Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated ...

  • Industries : Pathology, Drug and Medication, General Medicine and Specialty Medicine, Pharmaceutical, Drug Discovery and Development
Triple Analysis: Colorectal Cancer, Apoptosis and Peptides

Triple Analysis: Colorectal Cancer, Apoptosis and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Colorectal Cancer), one mechanism/target/effect area (Apoptosis) and one compound specific area (Peptides). ...

  • Industries : Drug and Medication, Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Drug Discovery and Development
Triple Analysis: Colorectal Cancer, Angiogenesis and Peptides

Triple Analysis: Colorectal Cancer, Angiogenesis and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Colorectal Cancer), one mechanism/target/effect area (Angiogenesis) and one compound specific area ...

  • Industries : Drug and Medication, Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Drug Discovery and Development
Triple Analysis: Colorectal Cancer, Protein Kinase Inhibitors and Peptides

Triple Analysis: Colorectal Cancer, Protein Kinase Inhibitors and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Colorectal Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific ...

  • Industries : Drug and Medication, Pathology, Pharmaceutical, General Medicine and Specialty Medicine, Drug Discovery and Development
Triple Analysis: Colorectal Cancer, Antibodies and Peptides

Triple Analysis: Colorectal Cancer, Antibodies and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in Colorectal Cancer and by the two compound strategies of Antibodies and Peptides. Each of these three individual parts is evaluated ...

  • Industries : Drug and Medication, Pathology, Pharmaceutical, Drug Discovery and Development, General Medicine and Specialty Medicine
Triple Analysis: Leukemia, Lung Cancer and Peptides

Triple Analysis: Leukemia, Lung Cancer and Peptides

  • $ 5 175
  • Industry report
  • January 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Leukemia and Lung Cancer and by the compound strategy of Peptides. Each of these three individual parts is evaluated according ...

  • Industries : Pathology, Drug and Medication, Pharmaceutical

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.